Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yixuan James Zheng

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of the American Academy of Dermatology|August 30, 2020
Poor melanoma outcomes and survival in Asian American and Pacific Islander patientsYixuan James Zheng, Clarice Ho, Ann Lazar, et al.
The Medical Clinics of North America|November 8, 2025
TracheotomyDaniel Gorelik, Yixuan James Zheng, Franklin Wu, et al.
The Laryngoscope|June 19, 2023
Snoring Patterns During Hypoglossal Nerve Stimulation Therapy Up-TitrationYixuan James Zheng, Yi Cai, Kene-Chukwu Ifeagwu, et al.
JAAD Case Reports|June 13, 2018
Cutaneous CD56<sup>+</sup> T-cell lymphoma developing during pembrolizumab treatment for metastatic melanomaYixuan James Zheng, Albert Lee, Laura Pincus, et al.
The Laryngoscope|March 22, 2024
Impact of Hypoglossal Nerve Stimulation on Consumer Sleep Technology Metrics and Patient SymptomsYi Cai, Yixuan James Zheng, Chloe M Cheng, et al.
Melanoma Research|August 22, 2022
Melanoma risk during immunomodulating treatmentYixuan James Zheng, Wilson Ho, Martina Sanlorenzo, et al.
Oncotarget|May 26, 2023
Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatmentValentin Feichtenschlager, Yixuan James Zheng, Wilson Ho, et al.
JAMA Otolaryngology-- Head & Neck Surgery|January 21, 2021
Patient Use of Low-cost Digital Videoscopes and Smartphones for Remote Ear and Oropharyngeal ExaminationsYi Cai, Yixuan James Zheng, Arushi Gulati, et al.
Molecular Cancer|February 21, 2024
The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanomaValentin Feichtenschlager, Linan Chen, Yixuan James Zheng, et al.
Research Square|December 11, 2023
The therapeutically actionable long non-coding RNA '<i>T-RECS</i>' is essential to cancer cells' survival in NRAS/MAPK-driven melanomaValentin Feichtenschlager, Linan Chen, Yixuan James Zheng, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of the American Academy of Dermatology|August 30, 2020
Poor melanoma outcomes and survival in Asian American and Pacific Islander patientsYixuan James Zheng, Clarice Ho, Ann Lazar, et al.
The Medical Clinics of North America|November 8, 2025
TracheotomyDaniel Gorelik, Yixuan James Zheng, Franklin Wu, et al.
The Laryngoscope|June 19, 2023
Snoring Patterns During Hypoglossal Nerve Stimulation Therapy Up-TitrationYixuan James Zheng, Yi Cai, Kene-Chukwu Ifeagwu, et al.
JAAD Case Reports|June 13, 2018
Cutaneous CD56<sup>+</sup> T-cell lymphoma developing during pembrolizumab treatment for metastatic melanomaYixuan James Zheng, Albert Lee, Laura Pincus, et al.
The Laryngoscope|March 22, 2024
Impact of Hypoglossal Nerve Stimulation on Consumer Sleep Technology Metrics and Patient SymptomsYi Cai, Yixuan James Zheng, Chloe M Cheng, et al.
Melanoma Research|August 22, 2022
Melanoma risk during immunomodulating treatmentYixuan James Zheng, Wilson Ho, Martina Sanlorenzo, et al.
Oncotarget|May 26, 2023
Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatmentValentin Feichtenschlager, Yixuan James Zheng, Wilson Ho, et al.
JAMA Otolaryngology-- Head & Neck Surgery|January 21, 2021
Patient Use of Low-cost Digital Videoscopes and Smartphones for Remote Ear and Oropharyngeal ExaminationsYi Cai, Yixuan James Zheng, Arushi Gulati, et al.
Molecular Cancer|February 21, 2024
The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanomaValentin Feichtenschlager, Linan Chen, Yixuan James Zheng, et al.
Research Square|December 11, 2023
The therapeutically actionable long non-coding RNA '<i>T-RECS</i>' is essential to cancer cells' survival in NRAS/MAPK-driven melanomaValentin Feichtenschlager, Linan Chen, Yixuan James Zheng, et al.
Pageof 1